Stay updated on Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the study details with an error screen; as a result, the trial record is inaccessible to users.
    Difference
    23%
    Check dated 2026-09-20T01:01:36.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The revision label on the study page was updated from v3.6.5 to v3.6.6, indicating a small metadata update to the record. This change does not modify the study content or data.
    Difference
    0.0%
    Check dated 2026-08-29T20:04:04.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.6.5 has been added, replacing the previous v3.6.4. This indicates the study documents have been updated to the new revision.
    Difference
    0.0%
    Check dated 2026-08-08T19:19:06.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    - The page revision was updated from v3.6.3 to v3.6.4, indicating a small metadata update to the study record. This does not change the study details, eligibility criteria, or outcomes.
    Difference
    0.0%
    Check dated 2026-07-25T11:42:37.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    No additions or deletions were identified for this page, indicating the content remained the same between versions.
    Difference
    0.0%
    Check dated 2026-07-18T09:20:24.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, signaling a small update to the page rather than changes to study details. This change reflects a backend or content polish and does not affect the recorded trial information presented on the page.
    Difference
    0.0%
    Check dated 2026-07-03T23:44:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page.